Tuesday
03.19.2024
9:04 AM
Login form
Search
Calendar
Entries archive

My site

Main » 2018 » October » 31

Latest round will accelerate product innovation and mass production of revolutionary S3 solid-state LiDAR and keeps IPO process on track


SUNNYVALE, Calif.-Wednesday 31 October 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Quanergy Systems, Inc., a global leader in the development and manufacture of LiDAR sensors and smart sensing solutions, today announced it has secured Series C funding at a valuation exceeding $2 billion, with a global top-tier fund as the lead investor.

Raising the Series C financing takes the company well beyond its planning horizons to cash-flow and operating breakeven, and keeps the company’s IPO process on track.

Demand for Quanergy’s solutions continues to be strong, with revenue increasing rapidly and bookings exceeding forecast. Product and software development continues at a brisk pace. Substantial orders for the company’s S3 solid-state sensor were fulfilled this year. Rapid innovation continues to increas ... Read more »

Views: 167 | Added by: africanewsline | Date: 10.31.2018 | Comments (0)

LONDON-Wednesday 31 October 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- More than 400 delegates from over 40 countries are expected to attend the 12th annual Global Residence and Citizenship Conference, which takes place next week (4–6 November) in Dubai.

Hosted by leading international citizenship and residence advisory firm Henley & Partners, this annual event has become the world’s largest and most significant conference on investment migration, bringing together presidents, prime ministers, senior government ministers and officials, leading academics, experienced industry professionals, and top-tier financial and business media.

Dr. Christian H. Kalin, Group Chairman of Henley & Partners, says residence- and citizenship-by-investment programs are very much the new frontier in terms of freedom, flexibility, and future-readiness. “The societal and economic value they are able to generate is truly extraordinary, which is why we are seeing ... Read more »

Views: 146 | Added by: africa-live | Date: 10.31.2018 | Comments (0)

Connecting cross-border shoppers to the vast reach of Western Union’s network


DENVER -Wednesday 31 October 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- The Western Union Company (NYSE: WU), a leader in cross-border, cross-currency money movement, today announced it is has been engaged by Amazon to launch a new payment option that allows international shoppers to pay in person, in local currency where available, for their online purchases. Amazon is focused on providing international customers with access to millions of products.

Western Union’s money movement platform will power a new payment option for cross-border customers shopping on Amazon.com. Customers in select countries will be able to shop on Amazon and pay in person, in local currency, through the Western Union® agent network.

“There are people in the world who want greater access to Amazon’s huge product selection but paying for those purchases has been a real o ... Read more »

Views: 139 | Added by: africa-live | Date: 10.31.2018

• Michel Pettigrew, President of the Executive Board and Chief Operating Officer, will retire from his operational activities, effective December 31, 2018

• Per Falk will be the next President of the Executive Committee and Chief Science Officer, effective January 1, 2019

 

SAINT-PREX, Switzerland-Wednesday 31 October 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Ferring Pharmaceuticals today announced that Michel Pettigrew, President of the Executive Board and Chief Operating Officer, will retire from his operational activities effective December 31, 2018. Per Falk, Chief Science Officer, will assume additional responsibility as President of the Executive Committee, effective January 1, 2019.

Michel has had an exceptional career at Ferring, taking the company from revenues of €345 million when he joined the company in 2001 to nearly €2 billion today. In addition, Ferring is now in the Top 50 Global Pharma Companies 2018.

... Read more »
Views: 159 | Added by: africa-live | Date: 10.31.2018

TOKYO, Japan & STRASBOURG, France -Tuesday 30 October 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- NEC Corporation (NEC)(TOKYO:6701) and Transgene (Euronext Paris:TNG) today announced the signing of a Memorandum of Understanding (MOU) for a strategic collaboration aimed at the treatment of solid cancers. The companies will cooperate in clinically assessing the predictive capabilities of NEC’s artificial intelligence (AI) and the therapeutic potential of Transgene’s myvac™ MVA-based viral vector platform in an individualized immunotherapy for the treatment of solid cancers. The experimental products from this collaboration are expected to enter clinical trials in 2019.

NEC and Transgene will co-invest in the first stage of development of an individualized immunotherapy, which includes clinical trials focusing on ovarian cancer and HPV-negative head and neck cancer.

Immunotherapy is rapidly becoming the treatment of choice to fight cancer as it a ... Read more »

Views: 149 | Added by: africa-live | Date: 10.31.2018 | Comments (0)

 New Phase 3 AMBER study data continues to demonstrate high rates of virologic suppression at 96 weeks in ART-naïve adults with HIV-1 when treated with D/C/F/TAF1

 

GLASGOW, Scotland-Tuesday 30 October 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- The Janssen Pharmaceutical Companies of Johnson & Johnson today unveiled 96-week results from the pivotal Phase 3 AMBER study of SYMTUZA® (darunavir 800 mg, cobicistat 150 mg, emtricitabine 200 mg and tenofovir alafenamide 10 mg (D/C/F/TAF)) at HIV Glasgow in Scotland. D/C/F/TAF is a once-daily darunavir-based single-tablet regimen (STR), for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents aged 12 years and older with body weight of at least 40 kg. Genotypic testing should guide the use of D/C/F/TAF.2

Results from the AMBER study demonstrated that a high proportion of antiretroviral treatment (ART)-naïve adults with HIV-1 (85%, 308/362) maintained vi ... Read more »

Views: 166 | Added by: africa-live | Date: 10.31.2018

EFD provides advanced primary packaging and controlled drug delivery systems for animal health products worldwide.

 

EAST PROVIDENCE, R.I. -Tuesday 30 October 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Nordson EFD, a Nordson company (NASDAQ: NDSN) and the world’s leading precision fluid dispensing systems manufacturer, announces its entry into a new market with the introduction of a comprehensive line of disposable dosing syringes for animal health products such as veterinary pharmaceuticals and nutritional supplements.

EFD leverages more than 50 years of experience in precision molding processes for its industrial fluid dispensing components to deliver high-quality, advanced primary packaging and controlled drug delivery syringes to the global animal health market.

Its industry-leading Dial-A-Dose™ syringes provide an innovative solution for end users to customize multiple doses for an animal based on the product manufacturer&rsqu ... Read more »

Views: 149 | Added by: africa-live | Date: 10.31.2018 | Comments (0)